Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Condition: Seborrheic Dermatitis Intervention: Drug: ARQ-154 foam or ARQ-154 vehicle Sponsor: Arcutis, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials